AAAAAA

   
Results: 1-18 |
Results: 18
Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations
Authors: La Spina, I Porazzi, D Maggiolo, F Bottura, P Suter, F
Citation: I. La Spina et al., Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations, EUR J NEUR, 8(1), 2001, pp. 71-75
Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution
Authors: Arici, C Ripamonti, D Ravasio, V Maggiolo, F Rizzi, M Finazzi, MG Suter, F
Citation: C. Arici et al., Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution, INT J STD A, 12(9), 2001, pp. 573-581
Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART
Authors: Arici, C Tebaldi, A Quinzan, GP Maggiolo, F Ripamonti, D Suter, F
Citation: C. Arici et al., Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART, INT J STD A, 12(6), 2001, pp. 407-409
Comparison of NNRTIs in antiretroviral-experienced patients
Authors: Maggiolo, F
Citation: F. Maggiolo, Comparison of NNRTIs in antiretroviral-experienced patients, INT J STD A, 12, 2001, pp. 10-17
Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART
Authors: Baldanti, F Paolucci, S Gulminetti, R Maserati, R Migliorino, G Pan, A Maggiolo, F Comolli, G Chiesa, A Gerna, G
Citation: F. Baldanti et al., Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART, ANTIVIR RES, 50(3), 2001, pp. 197-206
Duration of viral suppression in patients on stable therapy for HIV-1 infection is predicted by plasma HIV RNA level after 1 month of treatment
Authors: Maggiolo, F Migliorino, M Pirali, A Pravettoni, G Caprioli, S Suter, F
Citation: F. Maggiolo et al., Duration of viral suppression in patients on stable therapy for HIV-1 infection is predicted by plasma HIV RNA level after 1 month of treatment, J ACQ IMM D, 25(1), 2000, pp. 36-43
Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999)
Authors: Seminar, E Maggiolo, F Villani, P Suter, F Pan, A Regazzi, MB Paolucci, S Baldanti, F Tinelli, C Maserati, R
Citation: E. Seminar et al., Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999), J ACQ IMM D, 23(3), 2000, pp. 278-278
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus
Authors: Maggiolo, F Capra, R Bottura, P Pravettoni, G Migliorino, M Suter, F
Citation: F. Maggiolo et al., In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus, J CHEMOTHER, 12(3), 2000, pp. 195-198
Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model
Authors: Maggiolo, F Capra, R Bartoli, A Bottura, P Migliorino, M Suter, F
Citation: F. Maggiolo et al., Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model, J CHEMOTHER, 12(2), 2000, pp. 129-133
Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients
Authors: Baldanti, F Paolucci, S Maserati, R Maggiolo, F Pan, A Castelli, F Gulminetti, R Comolli, G Chiesa, A Gerna, G
Citation: F. Baldanti et al., Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients, EUR J CL M, 19(5), 2000, pp. 380-384
Different immunologic profiles characterize HIV infection in highly activeantiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia
Authors: Clerici, M Seminari, E Suter, F Castelli, F Pan, A Biasin, M Colombo, F Trabattoni, D Maggiolo, F Carosi, G Maserati, R
Citation: M. Clerici et al., Different immunologic profiles characterize HIV infection in highly activeantiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia, AIDS, 14(2), 2000, pp. 109-116
Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART
Authors: Paolucci, S Baldanti, F Maserati, R Castelli, F Suter, F Maggiolo, F Pan, A Gerna, G
Citation: S. Paolucci et al., Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART, ANTIVIR RES, 45(2), 2000, pp. 101-114
Management of infected peripheral bypass by selective partial graft removal and arterial homograft insertion - Two case reports
Authors: Locati, P Socrate, AM Costantini, E Maggiolo, F
Citation: P. Locati et al., Management of infected peripheral bypass by selective partial graft removal and arterial homograft insertion - Two case reports, J CARD SURG, 41(2), 2000, pp. 311-315
Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors
Authors: Seminari, E Maggiolo, F Villani, P Suter, F Pan, A Regazzi, MB Tinelli, C Maserati, R
Citation: E. Seminari et al., Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors, J ACQ IMM D, 22(5), 1999, pp. 453-460
Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors
Authors: Maggiolo, F Maserati, R Pan, A Castelli, F Suter, F
Citation: F. Maggiolo et al., Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors, AIDS, 13(12), 1999, pp. 1591-1592
Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy
Authors: Maggiolo, F Bottura, P Capra, R Pirali, A Zaffaroni, P Suter, F
Citation: F. Maggiolo et al., Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy, AIDS, 13(12), 1999, pp. 1594-1595
Elevated concentrations of plasma alpha-melanocyte stimulating hormone areassociated with reduced disease progression in HIV-infected patients
Authors: Airaghi, L Capra, R Pravettoni, G Maggiolo, F Suter, F Lipton, JM Catania, A
Citation: L. Airaghi et al., Elevated concentrations of plasma alpha-melanocyte stimulating hormone areassociated with reduced disease progression in HIV-infected patients, J LA CL MED, 133(3), 1999, pp. 309-315
Once-a-day HAART for HIV infection
Authors: Maggiolo, F Migliorino, M Maserati, R Rizzi, L Pravettoni, G Suter, E
Citation: F. Maggiolo et al., Once-a-day HAART for HIV infection, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 103-106
Risultati: 1-18 |